Table 3.
Study | ML Models | Dataset | Targets | Drugs | Ref. | |
---|---|---|---|---|---|---|
1 | AI approach fighting COVID-19 with repurposing drugs | Deep neural network | Drugs with known profiles | FIP and Covid-19 | 13/80 Drugs showed in-vitro activity | [80] |
2 | Deep Learning based prediction of Commercially available drugs | Deep learning-based, Molecule Transformer-Drug Target Interaction (MT-DTI) |
SMILES and DTIs | Covid-19 associated 3CLpro, RdRp, helicase, 3′-to-5′ exonuclease, endoRNAse, and 2′-O-ribose methyltransferase | 8 Drugs | [70] |
3 | machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection | mechanistic model | Drug targets, pathway genes, Gene expression | Covid-19 related signaling pathways and transduction circuits | – | [81] |
4 | Open Data to Discover Therapeutics for COVID-19 Using Deep Learning | Deep learning-based knowledge graph | Knowledge graph of 15 million edges across 39 types of relationships | Covid-19 | 41 Drugs | [72] |
5 | Repositioning of 8565 Existing Drugs for COVID-19 | 2-D fingerprint, GBDT model, Recurrent Neural Network (RNN) | Largest available experimental data set for SARS-CoV-2 or SARS-CoV 3CL (main) protease inhibitors | Covid-19 associated 3CLpro | 40 Drugs | [82] |
6 | Large scale virtual screening of ligand using DNN | Deep neural network enabled ChemAI | 220 M data points across 3.6 M molecules from three public drug-discovery databases | Covid-19 related 3CLpro, PLP | 20 Drugs | [83] |
7 | Deep learning enabled docking to rapidly identify the potential Covid-19 inhibitors | Deep learning-based Docking Platform | Purchasable compounds obtained from databases. (1.3 billion compounds from Zinc) | Covid-19 associated Mpro | 1000 Drugs | [78] |
8 | Prediction of potential commercially inhibitors against SARSCoV-2 by multi-task deep model | Multi-task deep learning model for classification and regression | Covid-19 related viral protein dataset | Covid-19 related 3CLpro | 10 Drugs | [84] |
9 | DeepPurpose: a deep learning library for drug–target interaction prediction | Convolutional neural network (CNN), Deep purpose | DTIs | Covid-19 related 3CLpro | 13 Drugs | [85] |
10 | Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies | Random forest (RF) regression algorithm, ensemble docking | DTIs | S, S-ACE2 complex | 187 Drugs | [86] |
11 | SARS-CoV-2 using ML from a > 10 million chemical space | Support vector machine (SVM), Random Forest (RF) | assay data of 65 Covid-19 host targets and purchasable 14 million chemicals | Covid-19 host targets | 58 Drugs | [87] |